Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells

Related Experiment Video

Updated: Sep 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Akira Kaji1, Yiguo Zhang, Masaaki Nomura

  • 1Hormel Institute, University of Minnesota, Austin, Minnesota 55912, USA.

Molecular Carcinogenesis
|July 29, 2003
PubMed

Insights

Pifithrin-alpha (PFTalpha) does not inhibit p53-mediated apoptosis; instead, it activates p53 signaling pathways. This finding challenges PFTalpha

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Pifithrin-alpha (PFTalpha) was previously reported as a specific inhibitor of p53-dependent apoptosis.
  • This property suggested PFTalpha's potential utility in mitigating cancer therapy side effects.

Purpose of the Study:

  • To investigate the effect of PFTalpha on p53-mediated transcriptional activation and apoptosis.
  • To determine if PFTalpha acts as a specific p53 inhibitor in JB6 cells.

Main Methods:

  • Treatment of JB6 cells with PFTalpha, UVB, or doxorubicin (Dox).
  • Assessment of p53-mediated transcriptional activation and apoptosis.
  • Analysis of kinase activation (ERK, p38, JNK) and p53 phosphorylation/accumulation.

Main Results:

  • PFTalpha did not inhibit UVB- or Dox-stimulated p53 activation and apoptosis in JB6 cells.
  • PFTalpha alone, and in combination with UVB or Dox, induced and enhanced p53-dependent apoptosis.
  • PFTalpha-induced apoptosis involved both p53-dependent and -independent pathways, with activation of ERK and p38 kinases.

Conclusions:

  • PFTalpha is not a specific p53 inhibitor in JB6 cells.
  • PFTalpha acts as a potential activator of p53-mediated signaling and apoptosis.
  • ERK and p38 kinase activation are crucial for PFTalpha's effect on p53.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...